Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/19995399

Download in:

View as

General Info

PMID
19995399